Researcher at Harvard Medical School develops AI-driven molecule targeting tumor mitochondria defects to destroy cancer ...

Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ STOCKHOLM: HNSA), today published its Annual and Sustainability Reports for 2025.

The Classical Learning Test is unique among summative assessments in that it focuses entirely on classical texts. The ...

20.48 In 2025, the company's net pro?t attributable to the parent company increased by 20.48% 2 R&D investment grew by 9.96% Overseas sales revenue rose by 45.52%. 9.96 45.52 HGTECH deeply implements ...

Ferrovial is celebrating 15 years of its global social initiatives, having supported over 480,000 people across 14 countries through its “On the Move for Water” and “On the Move for Zero Hunger” ...

DNV has published new research identifying key principles for building trustworthy artificial intelligence in safety-critical industrial settings, emphasizing that established risk management and ...

Hansa Biopharma AB, "Hansa" or the "Company" (NASDAQ STOCKHOLM: HNSA), today published its Annual and Sustainability Reports for 2025. Peter ...

Strong balance sheet with $360.0 million in cash, cash equivalents and marketable securities; expected cash runway into 2028 SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Maze ...